Non-persistence regarding all first-line glaucoma monotherapies and the two most common glaucoma drug classes during the follow-up between 1995 and 2019 in the FinHealth 2017 Survey sample representing the Finnish adult population aged 30 years or older.
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Non-persistence regarding all first-line glaucoma monotherapies and the two most common glaucoma drug classes during the follow-up between 1995 and 2019 in the FinHealth 2017 Survey sample representing the Finnish adult population aged 30 years or older.
创建时间：
2025-01-30
